Clinical trial • Phase III • Psychiatry
sertraline for Anorexia nervosa
Phase III trial of sertraline for Anorexia nervosa. None/Not specified-controlled. 8 participants.
Overview
- Trial Therapeutic Area
- Psychiatry
- Trial Disease
- Anorexia nervosa
- Trial Stage
- Phase III
- Drug Modality
- Small molecule
Key dates
- Initial CTIS Submission Date
- 09-04-2024
- First CTIS Authorization Date
- 21-05-2024
Trial design
None/Not specified-controlled Phase III trial across 1 site in Austria.
- Comparator
- None/Not specified
- Target Sample Size
- 8
Recruitment
- Planned Sample Size
- 8
- Recruitment Window Months
- 118
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 8
Austria
- Earliest CTIS Part Ii Submission Date
- 22-04-2024
- Latest Decision Or Authorization Date
- 21-05-2024
- Processing Time Days
- 29
- Number Of Sites
- 1
- Number Of Participants
- 8
Sites
- Site Name
- Medical University Of Vienna, Waehringer Guertel 18-20
- Department Name
- Department of Clinical Pharmacology
- Principal Investigator Name
- Markus Zeitlinger
- Principal Investigator Email
- markus.zeitlinger@meduniwien.ac.at
- Contact Person Name
- Markus Zeitlinger
- Contact Person Email
- markus.zeitlinger@meduniwien.ac.at
- Number Of Participants
- 8
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Investigational products
- Investigational Product Name
- sertraline
- Active Substance
- sertraline
- Modality
- Small molecule
- Routes Of Administration
- oral
- Route
- oral
Related trials
Other published trials that may interest you.